Risultati della ricerca - F Pane

P190 | ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION: A PROMISING SALVAGE STRATEGY FOR YOUNG, FIT PATIENTS WITH FIRST-RELAPSE MULTIPLE MYELOMA. di R. Della Pepa, Aldo Leone, S. Avilia, F. Pane.

Testo

Coding Readiness Assessment: A Measure of Computational Thinking for Preschoolers di Emily Relkin, Christopher Doss, Victoria L. Jones, John F. Pane

Testo

P192 | PERSISTENT CYTOKINE RELEASE SYNDROME IN PATIENTS RECEIVING BISPECIFIC ANTIBODY THERAPY FOR MULTIPLE MYELOMA: A CASE SERIES di R. Della Pepa, A. Leone, F. Grimaldi, S. Avilia, M. Memoli, F. Pane.

Testo

P137 | FOSTAMATINIB IN COMBINATION WITH TPO-RA AS TREATMENT IN PATIENTS WITH MULTIREFRACTORY IMMUNE THROMBOCYTOPENIA di V. Sammartano, C. Giordano, C. Grieco, M. Fevola, E. Parlato, A. Ucciero, G. Verrengia, F. Pane.

Testo

P202 | FRONTLINE NILOTINIB VS DASATINIB IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: A PROPENSITY SCORE ANALYSIS BASED ON AIFA MONITORING REGISTRIES di M. Breccia, P.P. Olimpieri, F. Pane, S. Celant, A. Iurlo, V. Summa, P. Corradini, P. Zinzani

Testo

S286: LONG-TERM EFFICACY AND SAFETY RESULTS FROM AN ONGOING OPEN-LABEL PHASE 2 STUDY OF PARSACLISIB FOR THE TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) di W. Barcellini, I. Murakhovskaya, L. Terriou, F. Pane, A. Patriarca, K. Butler, S. Moran, S. Wei, U. Jäger

Testo

PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON-HODGKIN LYMPHOMA: A MONOCENTRIC... di S. Di Folca, V. Marafioti, S. barbato, S. Avilia, F. Grimaldi, A. Severino, M. Picardi, L. Luciano, G. Battipaglia, F. Pane

Testo

C068 | PROGNOSTIC VALUE AT BASELINE OF CANCER GENE VARIANTS IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE SINGLE-CENTRE STUDY di C. Ielo, G. Iaquinta, E. Scalzulli, I. Carmosino, M. Bisegna, P. Fazi, M. Martelli, P. Grammatico, F. Pane

Testo

P697: PONATINIB IN A REAL-LIFE SETTING: A RETROSPECTIVE ANALYSIS FROM THE MONITORING REGISTRIES OF THE ITALIAN MEDICINES AGENCY (AIFA) di M. Breccia, P. P. Olimpieri, S. Celant, O. M. Olimpieri, F. Pane, A. Iurlo, V. Summa, P. Corradini, P. Russo

Testo

P56 | BASELINE IMMUNE PROFILE PREDICTS RESPONSE TO BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD MONOCENTRIC EXPLORATORY ANALYSIS di R. Della Pepa, A. Leone, L. Esposito, G.L. D'Elia, V. Cerbone, M. Raia, G. Scalia, F. Pane

Testo

P1023: COHORT ANALYSIS OF MPN PATIENTS WITH CONCOMITANT MGUS DIAGNOSIS: A RETROSPECTIVE STUDY di C. Fatigati, F. Antonucci, L. De Fazio, R. Iannotta, M. Lamagna, A. Leone, F. Muriano, G. Scairati, F. Pane, N. Pugliese

Testo

Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort stud... di Claudia Giordano, M. Picardi, F. Esposito, A. Vincenzi, N. Pugliese, A. Lombardi, F. Trastulli, R. Secchi, M. Postorino, M. Annunziata, A. Venditti, F. Pane

Testo

P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA di R Iula, F Trastulli, R Della Pepa, A D’Ambrosio, M Romano, A Leone, G Gaeta, S Palmieri, S Rocco, F Pane, F Ferrara, L Catalano

Testo

P664: GRADING QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS FOR THE TREATMENT OF RELAPSED/REFRACTORY CLL. di S. Molica, C. Patti, P. Sportoletti, A. Chiarenza, A. M. Giordano, F. Chiurazzi, N. Di Renzo, P. Musto, F. Pane, F. Di Raimondo, L. Trentin, F. R. Mauro, D. Giannarelli

Testo

DP107 | MONITORING OF MINIMAL RESIDUAL DISEASE ON PERIPHERAL BLOOD IN THE POST-TRANSPLANT PERIOD ALLOWS AVOIDANCE OF REPEATED BONE MARROW ASPIRATIONS IN PATIENTS WITH ACUTE MYELOID... di A. Perrotta, C. Causa, G. Petricciuolo, S. Barbato, A. Cacace, L. Esposito, M. Lamagna, A. Maddaloni, L. Piccolo, F. Grimaldi, M. Memoli, S. Avilia, S. Iaccarino, L. Ammirati, N. Frigeri, C. Califano, F. Pane

Testo

C020 | REAL-WORLD OUTCOMES OF ROPEGINTERFERON ALFA-2B IN POLYCYTHEMIA VERA: IMPACT OF EARLY DOSE ESCALATION AND TREATMENT DURATION ON HEMATOLOGIC RESPONSE di N. Pugliese, H. Catellani, M. Di Perna, M. Romano, C. Martorelli, M.M. Spiezia, L. De Fazio, E. Rinaldi, M. Annunziata, D.P. Abagnale, U. De Martino, R. Russo, V. Martinelli, F. Pane

Testo

P091 | LUSPATERCEPT IN LOW-RISK MYELODYSPLASTIC SYNDROME WITH RING SIDEROBLASTS: A LONG-TERM REAL-LIFE EXPERIENCE di S. Leone, M. Di Perna, C. Califano, D. De Novellis, I. Ferrara, A. Malandrini, C. Selleri, C. Frieri, G. Gaeta, C. Masucci, A. D’ambrosio, P. Della Cioppa, T. Izzo, M. Annunziata, A. Maddaloni, C. Quagliano, N. Pugliese, S. Avilia, F. Grimaldi, F. Pane, M. Memoli

Testo

P107 | CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN THE REAL WORD :THE CAMPANIA EXPERIENCE WITH FIRST –LINE IBRUTINIB AND VENETOCLAX di G. Farina, M. Lucignano, M. Rosaria Villa, L. Mettivier, B. Pocali, V. Amico, A. Fresa, C. Giordano, F. Graziani, R. Reina, A. Pareto, M.G. Ferrara, M. Di Palma, M. Troiano, V. Sammartano, F. Trastulli, G. D'arena, G. Rodolfo Nunziata, C. Califano, F. Pane

Testo

P174 | EFFICACY AND SAFETY OF ISATUXIMAB, CARFILZOMIB AND DEXAME-THASONE (ISAKD) IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION AND LENALI... di N. Sgherza, P. Curci, O. Battisti, C. Conticello, S. Palmieri, D. Derudas, C. Germano, E.A. Martino, G. Mele, R. Della Pepa, F. Fazio, A. Mele, B. Rossini, G. Palazzo, D. Roccotelli, S. Rasola, M.T. Petrucci, D. Pastore, G. Tarantini, F. Pane, M. Gentile, F. Di Raimondo, E. Resta, P. Musto

Testo

DP023 | LUSPATERCEPT FOR THE TREATMENT OF TRANSFUSION-DEPENDENT ANEMIA IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS WITH DEL5Q, REFRACTORY/RESISTANT/INTOLERANT TO PRIOR TREATMENTS (Q... di E.N. Oliva, M. Riva, C. Frairia, E. Crisà, A. Poloni, C. Alati, I. Capodanno, F. Pane, A. Castelli, C. Gurnari, M.T. Voso, G. Zini, M.G. D’errigo, C. Mammì, G. Iannì, D. Griguolo, M. Marchetti, S. Barillà, I. E. Bova, M.C. Cannatà, L. Rizzo, I.M. Delfino, B. Fattizzo

Testo